Monoclonal Antibodies in Neurology: Current State and Future Development

Monoclonal antibodies are one of the fastest growing areas of specific therapy for cancer, infectious, autoimmune, and demyelinating diseases. The main targets of monoclonal antibodies in autoimmune and demyelinating diseases are T and B lymphocytes, cytokines, complement, and adhesion molecules. In...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Human physiology Ročník 48; číslo 8; s. 932 - 937
Hlavný autor:	Zakharova, M. N.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Moscow Pleiades Publishing 01.12.2022 Springer Nature B.V
Predmet:	Alzheimer's disease Autoimmune diseases Biomedical and Life Sciences Biomedicine CD19 antigen CD20 antigen Demyelinating diseases Demyelination Human Physiology Life Sciences Lymphocytes B Monoclonal antibodies Multiple sclerosis Nanobodies Neurodegenerative diseases Neuromyelitis Parenchyma β-Amyloid nanobodies Alzheimer’s disease demyelinating diseases multiple sclerosis neuromyelitis optica monoclonal antibodies
ISSN:	0362-1197, 1608-3164
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!